58 related articles for article (PubMed ID: 7674311)
21. Cytotoxic activity of some natural and synthetic guaianolides.
Bruno M; Rosselli S; Maggio A; Raccuglia RA; Bastow KF; Lee KH
J Nat Prod; 2005 Jul; 68(7):1042-6. PubMed ID: 16038545
[TBL] [Abstract][Full Text] [Related]
22. [Study on taxol release in the two-liquid-phase cultures of Taxus cuspidata].
Wu ZL; Di JS; Yuan YJ; Hu ZD
Sheng Wu Gong Cheng Xue Bao; 2000 Jul; 16(4):500-4. PubMed ID: 11051828
[TBL] [Abstract][Full Text] [Related]
23. [A new, more expensive agent against ovarian cancer. Worth its price?].
Högberg T; Karlsson G; Ridderheim M; Boman K; Frankendal B; Horvath G; Sorbe B; Strang P; Rosenberg P
Lakartidningen; 1997 Jan; 94(1-2):21-4. PubMed ID: 9053597
[No Abstract] [Full Text] [Related]
24. Rearrangement of O-cinnamoyltaxicin I to a novel C-13 spiro-taxane.
van Rozendaal EL; Veldhuis H; van Veldhuizen B; van Beek TA; de Groot A; Beusker PH; Scheeren HW
J Nat Prod; 2000 Feb; 63(2):179-81. PubMed ID: 10691703
[TBL] [Abstract][Full Text] [Related]
25. Effects of inoculum size and age on biomass growth and paclitaxel production of elicitor-treated Taxus yunnanensis cell cultures.
Zhang CH; Wu JY; He GY
Appl Microbiol Biotechnol; 2002 Dec; 60(4):396-402. PubMed ID: 12466878
[TBL] [Abstract][Full Text] [Related]
26. Practical synthesis of Taxol side chain.
Ha HJ; Park GS; Ahn YG; Lee GS
Bioorg Med Chem Lett; 1998 Jul; 8(13):1619-22. PubMed ID: 9873401
[TBL] [Abstract][Full Text] [Related]
27. The billion dollar molecule: Taxol in historical and theoretical perspective.
Walsh V; Goodman J
Clio Med; 2002; 66():245-67. PubMed ID: 12028680
[No Abstract] [Full Text] [Related]
28. Drugmakers fight for good name. Stakes high, challenges many for providers who seek generic products.
Becker C
Mod Healthc; 2001 Aug; 31(35):28-33, 1. PubMed ID: 11550428
[TBL] [Abstract][Full Text] [Related]
29. Treatment with paclitaxel alone rather than combination with paclitaxel and cisplatin may be selective for cisplatin-resistant ovarian carcinoma.
Yamamoto K; Kikuchi Y; Kudoh K; Hirata J; Kita T; Nagata I
Jpn J Clin Oncol; 2000 Oct; 30(10):446-9. PubMed ID: 11185891
[TBL] [Abstract][Full Text] [Related]
30. Preparation of phenolic paclitaxel metabolites.
Park H; Hepperle M; Boge TC; Himes RH; Georg GI
J Med Chem; 1996 Jul; 39(14):2705-9. PubMed ID: 8709100
[TBL] [Abstract][Full Text] [Related]
31. Semisynthesis and cytotoxicity of styryl-lactone derivatives.
Bermejo A; Léonce S; Cabedo N; Andreu I; Caignard DH; Atassi G; Cortes D
J Nat Prod; 1999 Aug; 62(8):1106-9. PubMed ID: 10479313
[TBL] [Abstract][Full Text] [Related]
32. Taxol production in plant cell culture comes of age.
Pezzuto J
Nat Biotechnol; 1996 Sep; 14(9):1083. PubMed ID: 9631053
[No Abstract] [Full Text] [Related]
33. Practical synthesis of the C-ring precursor of paclitaxel from 3-methoxytoluene.
Fukaya K; Yamaguchi Y; Watanabe A; Yamamoto H; Sugai T; Sugai T; Sato T; Chida N
J Antibiot (Tokyo); 2016 Apr; 69(4):273-9. PubMed ID: 26860468
[TBL] [Abstract][Full Text] [Related]
34. Bristol-Myers Squibb involved in developing alternative sources of TAXOL.
Anticancer Drugs; 1993 Aug; 4(4):517-20. PubMed ID: 8104545
[No Abstract] [Full Text] [Related]
35. 20th Belgian-Dutch LOF-Symposium on Pharmacognosy and Natural Products Chemistry. Paclitaxel and other taxanes as new anti-cancer drugs. Leiden, The Netherlands, 24 November 1995. Abstracts.
Pharm World Sci; 1995 Nov; 17(6 Suppl N):N1-14. PubMed ID: 8601148
[No Abstract] [Full Text] [Related]
36. [Preliminary results on a group of researches on medicinal plants].
Mariani A
Ric Sci; 1966 Apr; 36(4):295-300. PubMed ID: 5947233
[No Abstract] [Full Text] [Related]
37. [Pharmaceutical biology in the spotlight].
Heide L
Pharm Unserer Zeit; 1994 Apr; 23(2):100-4. PubMed ID: 7910969
[No Abstract] [Full Text] [Related]
38. [Studies on the anatomical structure of Galium ruthenicum W].
Borisov MI
Farm Zh; 1965; 20(5):59-63. PubMed ID: 5888689
[No Abstract] [Full Text] [Related]
39. The quest of the cubebs.
Edwards VS
JAMA; 1968 Sep; 206(1):133. PubMed ID: 5695438
[No Abstract] [Full Text] [Related]
40. Semisynthetic Taxol goes on market amid ongoing quest for new versions.
McNeil C
J Natl Cancer Inst; 1995 Aug; 87(15):1106-8. PubMed ID: 7674311
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
